<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02089165</url>
  </required_header>
  <id_info>
    <org_study_id>RISU 58/2013</org_study_id>
    <nct_id>NCT02089165</nct_id>
  </id_info>
  <brief_title>Bioavailability of Fatty Acids From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.</brief_title>
  <acronym>RISU</acronym>
  <official_title>Randomized, Single-center, Open-label, Blinded Endpoint Assessment Study (Cross-over Study With 3 Study Products) on Bioavailability of Fatty Acids (Plasma Lipid Fractions) From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Olympic Seafood AS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oy Foodfiles Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Olympic Seafood AS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the acute bioavailability of two different krill oil
      products called krill oil and krill meal in comparison to fish oil product.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma phospholipids.</measure>
    <time_frame>0-72 h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma triglyceride.</measure>
    <time_frame>0-72 h</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Mean proportions of fatty acids in plasma phospholipids and triglycerides.</measure>
    <time_frame>0-72 h</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Krill oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The interventions are administered in the randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Krill meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The interventions are administered in the randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fish oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The interventions are administered in the randomized order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Krill oil</intervention_name>
    <description>Krill oil from Antarctic krill, per oral, capsule, targeted daily n-3 PUFA dose of 1 700 mg, single administration</description>
    <arm_group_label>Krill oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Krill meal</intervention_name>
    <description>Krill meal, granular meal from Antarctic krill, per oral, targeted daily n-3 PUFA dose of 1 700 mg, single administration</description>
    <arm_group_label>Krill meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish oil</intervention_name>
    <description>Fish oil, per oral, capsule, targeted daily n-3 PUFA dose of 1 700 mg, single administration</description>
    <arm_group_label>Fish oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy female and male

          -  Age 18 - 65 years

          -  Body mass index 18.5 - 30

          -  Informed consent, signed

        Exclusion Criteria:

          -  Medication potential to affect the bioavailability of fatty acids (e.g. lipid-lowering
             drugs)

          -  Familial hypercholesterolemia, marked combined hyperlipidemia, condition that would
             impair, fat absorption (e.g. chronic pancreatitis, pancreatic lipase deficiency
             syndrome)

          -  Any untreated medical condition affecting absorption of fat

          -  Type 1 and 2 diabetes

          -  Cancer or other malignant disease within past five years

          -  Periodical hormone replacement therapy

          -  High intake of oily fish (once a week or more) (i.e. salmon, herring, sardines,
             mackerel, vendace)

          -  Smoking

          -  Alcohol consumption &gt; 15 doses per week

          -  Females who are pregnant, breast-feeding or intend to become pregnant

          -  Hypersensitivity to any of the components of the test product

          -  Regular use of n-3 supplements 4 weeks before randomization

          -  Lack of suitability for participation in the trial, for any medical reason, as judged
             by the principal investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Essi S Sarkkinen, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Oy Foodfiles Ltd, member of Foodfiles group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sakari A Nieminen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oy Foodfiles Ltd, memeber of Foodfiles group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oy Foodfiles Ltd, memeber of Foodfiles group</name>
      <address>
        <city>Kuopio</city>
        <zip>70210</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2014</study_first_submitted>
  <study_first_submitted_qc>March 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2014</study_first_posted>
  <last_update_submitted>June 3, 2014</last_update_submitted>
  <last_update_submitted_qc>June 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

